In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held on October 3, 2023. In this session, Surgical Oncologist Dr. Mark Basik answers your questions about clinical trials. In the parentheses, you’ll find the timestamp of where to find the question in the on-demand video.

The European Society of Medical Oncology held their annual congress in Madrid, Spain from October 20-24, 2023. Members of the CBCN team had the opportunity to attend and learn about the latest research to be announced for breast cancer. Here are some of those highlights.

The 2023 American Society of Clinical Oncology (ASCO) annual meeting was held from June 2 to 6. CBCN was pleased to be able to attend and participate in the many interesting and groundbreaking research that was shared at ASCO this year. Below, we present a few highlights and takeaways from this year’s conference.

Each year, May 20^th is recognized as Clinical Trials Day across the globe. In honor of this, we are highlighting various multi-centre clinical trials that are currently recruiting participants. Clinical trials are important for the advancement of cancer treatment and care, as well as important in improving the standard-of-care.

A cancer diagnosis comes with many questions. While some of those questions can be answered by your healthcare team, many others cannot. That’s why we have put together this “For the Newly Diagnosed’ two-part series; to help patients who have been newly and recently diagnosed get the answers to their most pressing questions that may not be easily answerable. This series is also meant to help patients get ready for and be aware of challenges they may face in the upcoming months.

Have you ever found yourself confused and wondering what all those scientific terms mean in the research studies we share on breast cancer? If so, we’ve compiled a list of common terms used in various breast cancer news articles to help explain how they are used in determining the results and progress of clinical trials and research.

This World Cancer Day, the focus is on how to ‘Close the Care Gap’. It is a call for everyone to not only become aware of the inequities that exist in cancer care, but to get actively involved in addressing and reducing such inequities. These inequities can be due to systemic and social barriers, as well as general access to care. While such gaps exist, they can be reduced and eventually eliminated. Below, we outline what CBCN is doing to close the breast cancer care gap and what you can do too.

Breast cancer research continues to show promising results and advances in the detection and treatment of the disease. More and more, work is being done in this area and studies provide hope to those diagnosed and living with breast cancer. With article headings boasting about new, better, and less invasive ways to treat breast cancer, it is important to understand the actual findings of the study and not get caught up in exciting headlines and summaries. In other cases, you may come across the results of a study from a news article or elsewhere online.

Carla Van Wyck-MacDonald lives near Shallow Lake, Ontario with her husband and their four children, ages 9, 11, 13 and 14. Carla was initially diagnosed with breast cancer two years after her mother died from the same disease.

Research on breast cancer, and more specifically, metastatic breast cancer (mBC), is critical in helping us better understand this disease. While widespread knowledge of mBC is still limited, there are studies that look specifically at the detection, prognosis and treatment of this type of breast cancer. Similarly, clinical trials on metastatic breast cancer are crucial in helping researchers improve the current standard of care. Below are some of the latest research and some currently recruiting clinical trials on metastatic breast cancer.

In part 1 of our blog series on clinical trials, we explained what clinical trials are, why you should participate in them and how to get more information about participating. You may now be familiar with clinical trials but still hesitant about enrolling in one because of certain concerns that you may have. These concerns are valid as many breast cancer patients have these same concerns. However, some of these concerns about clinical trials are ill-informed. In part 2 of our blog series on clinical trials, we debunk some of the most common myths surrounding clinical trials. We hope that this will provide you with some fact-based information to make a more informed decision about whether or not clinical trials are right for you.

According to a 2014 study by the Canadian Partnership Against Cancer, less than 7% of adult cancer patients enrolled in clinical trials.¹ This may be because many cancer patients are not aware of clinical trials, do not know how to enroll in them or are concerned that they are unsafe. In part one of our blog series on clinical trials, we explain what clinical trials are to provide you with the right tools to decide whether you should enroll in a clinical trial.

Are you looking for a clinical trial but not sure how to start or where to go? A new Clinical Trials Finder has been developed by Clinical Trials Ontario (CTO) to help you. You can search for a clinical trial in any province or territory in Canada, using only a few simple search terms.

I have been living with metastatic breast cancer for over eight years. While I am usually averse to using battle analogies for living with and dying from cancer, finding the best care has required a fight, considerable perseverance, and hard work. Fortunately, my ER+/PR+ tumours (pleura/liver/lymph) have responded well, but not great, to hormonal therapies.  I’m onto my seventh line of treatment. 

Biosimilar drugs will soon be entering the breast cancer treatment landscape and are already available for support medications. With these emerging treatment options, it’s important to know more about them so you can make informed decisions about your treatment plan.

Clinical trials play a big role in the discovery of new treatments for cancer. They help to determine the safety and effectiveness of potential new treatments. For metastatic patients, they can also potentially offer additional treatment options after the cancer has grown resistant to the standards of care.

I have never been a fan of roller coasters, too much up and down, made me feel sick.  Ironically, my life seems to have become a gigantic roller coaster ride!